Arcturus Therapeutics
ARCT
ARCT
22 hedge funds and large institutions have $9.58M invested in Arcturus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.44% more ownership
Funds ownership: 7.65% → 10.09% (+2.4%)
Holders
22
Holding in Top 10
–
Calls
$35K
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$290K | |
| 3 | +$70.8K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$48K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22K |
Top Sellers
| 1 | -$161K | |
| 2 | -$42.9K | |
| 3 | -$42.9K | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$16K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$9K |